Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

040. Bacteremia: Thursday, 12:15 - 1:30 p.m.

Poster Session: Bacteremia

(182) Piperacillin/tazobactam (P/T) versus meropenem (Mero) for treatment of extended-spectrum beta-lactamase (ESBL)-producing E.coli and K. pneumoniae bloodstream infections (BSIs)

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Co-Author(s)

  • AC

    Alexandra L. Cox, PharmD

    Atrium Health Wake Forest Baptist
    Winston-Salem, Virginia, United States

    • Presenting Author(s)

  • James R. Beardsley, PharmD

    Assistant Professor
    Wake Forest University School of Medicine
    Winston Salem, North Carolina, United States

    • Co-Author(s)

  • John C. Williamson, PharmD

    Program Administrator, Infectious Diseases Research
    Atrium Health Wake Forest Baptist
    Winston-Salem, NC, United States

  • Tyler J. Stone, PharmD

    Clinical Specialist, Infectious Diseases
    Wake Forest Baptist Health
    Winston-Salem, North Carolina, United States

  • Michael E. DeWitt, MS

    Research Data Scientist
    Atrium Wake Forest Baptist Health/ Wake Forest University School of Medicine
    Winston-Salem, North Carolina, United States

  • Elizabeth Palavecino, M.D.

    Director Microbiology Laboratory
    Wake Forest School of Medicine
    Winston Salem, North Carolina, United States

  • Vera Luther, MD

    Professor of Medicine
    Wake Forest University School of Medicine
    Winston Salem, NC, United States

  • AT

    Alex D. Taylor, PharmD

    Atrium Health Wake Forest Baptist
    Kernersville, North Carolina, United States